Grow Funds, an investment Advisor, released its Q1 2026 investor letter for “GROW Small Cap Equity Long/Short Fund”. A copy of the letter can be downloaded here. In Q1 2026, GROW Small Cap Equity Long/Short L.P (Fund) returned 4.18%, outperforming the Russell 2000 Growth Index’s –2.80%, HFRI Equity Hedge Index’s -0.24%, and the HFRI Fundamental Growth Index’s 0.47% returns. Long positions and hedges, and short positions, safeguarded the portfolio amid the volatility driven by the Iran War. In addition, please check the Strategy’s top five holdings to know its best picks in 2026.
In its first-quarter 2026 investor letter, Grow Funds highlighted stocks like Harrow, Inc. (NASDAQ:HROW). Harrow, Inc. (NASDAQ:HROW) is a US-based pharmaceutical company that focuses on the discovery and development of ophthalmic pharmaceutical products. On June 22, 2026, Harrow, Inc. (NASDAQ:HROW) closed at $42.41 per share. One-month return of Harrow, Inc. (NASDAQ:HROW) was 24.11%, and its shares gained 33.74% over the past 52 weeks. Harrow, Inc. (NASDAQ:HROW) has a market capitalization of $1.58 billion.
Grow Funds stated the following regarding Harrow, Inc. (NASDAQ:HROW) in its Q1 2026 investor letter:
“Harrow, Inc. (NASDAQ:HROW) develops ophthalmic therapies, helping patients manage chronic and acute eye conditions. While we like the company and its growth prospects, we thought that there was a disconnect in high street earnings expectations versus the underlying growth of the company. HROW disappointed on earnings and we covered the position.”
Harrow, Inc. (NASDAQ:HROW) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 22 hedge fund portfolios held Harrow, Inc. (NASDAQ:HROW) at the end of the first quarter, compared to 24 in the previous quarter. While we acknowledge the risk and potential of Harrow, Inc. (NASDAQ:HROW) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than HARROW, INC. (NASDAQ:HROW) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In another article, we covered Harrow, Inc. (NASDAQ:HROW) and shared a bullish thesis on the company. In addition, please check out our hedge fund investor letters Q1 2026 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. This article is originally published at Insider Monkey.
